|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0032854,
umls-concept:C0033325,
umls-concept:C0035647,
umls-concept:C0205282,
umls-concept:C0229671,
umls-concept:C0441889,
umls-concept:C0445204,
umls-concept:C0540511,
umls-concept:C0677886,
umls-concept:C0919267,
umls-concept:C1561558
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-12-1
|
|
pubmed:abstractText |
The aims of the study were to explore the levels of angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) in patients with benign, borderline, or malignant epithelial ovarian tumors and to compare them to those of healthy controls. In addition, we aimed to study how Ang-1 and Ang-2 levels predict the clinical course and survival of patients with epithelial ovarian cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1525-1438
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1498-505
|
|
pubmed:meshHeading |
pubmed-meshheading:21119365-Adolescent,
pubmed-meshheading:21119365-Adult,
pubmed-meshheading:21119365-Aged,
pubmed-meshheading:21119365-Aged, 80 and over,
pubmed-meshheading:21119365-Angiopoietin-1,
pubmed-meshheading:21119365-Angiopoietin-2,
pubmed-meshheading:21119365-Carcinoma,
pubmed-meshheading:21119365-Case-Control Studies,
pubmed-meshheading:21119365-Female,
pubmed-meshheading:21119365-Humans,
pubmed-meshheading:21119365-Middle Aged,
pubmed-meshheading:21119365-Neoplasm Staging,
pubmed-meshheading:21119365-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:21119365-Ovarian Neoplasms,
pubmed-meshheading:21119365-Preoperative Period,
pubmed-meshheading:21119365-Prognosis,
pubmed-meshheading:21119365-Survival Analysis,
pubmed-meshheading:21119365-Tumor Markers, Biological,
pubmed-meshheading:21119365-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.
|
|
pubmed:affiliation |
Department of Molecular Medicine, University of Eastern Finland, Department of Gynaecology and Obstetrics, Kuopio University Hospital, Kuopio, Finland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
